Test Your Tardive Dyskinesia Knowledge Now!
How much do YOU know about tardive dyskinesia? Test your knowledge now!
Read MoreDec 14, 2023
How much do YOU know about tardive dyskinesia? Test your knowledge now!
Read MoreDec 6, 2023
Test your knowledge of the latest prostate cancer studies and news—take this quiz!
Read MoreNov 29, 2023
An innovative, curated eBook featuring insightful tardive dyskinesia findings, articles and condition-related input from neurology experts.
Read MoreNov 14, 2023
The following is a summary of “Prognostic utility of RECIP 1.0 with manual and AI-based...
Read MoreNov 14, 2023
An analysis of 12 clinical trials shows no difference in mortality risk with continuous versus intermittent androgen deprivation therapy for prostate cancer.
Read MoreNov 14, 2023
Healthcare professionals should consider a complete therapeutic approach that includes the input of caregivers assisting patents with TD.
Read MoreNov 11, 2023
Both Black and White patients with metastatic castration-sensitive prostate cancer (mCSPC) showed similar progression-free survival and overall survival in a clinical trial setting.
Read MoreNov 11, 2023
The following is a summary of “BRCA-deficient metastatic prostate cancer has an adverse...
Read MoreNov 10, 2023
A curated ebook on prostrate cancer featuring recent studies, findings, and opinions from thought leaders.
Read MoreNov 1, 2023
A quiz based on the latest lung cancer biomarkers news and studies.
Read MoreOct 27, 2023
Resting-state functional MRI results show that patients with schizophrenia and tardive dyskinesia have altered cerebral regional homogeneity.
Read MoreOct 23, 2023
Physicians typically address movement disorders, such as tardive dyskinesia, during in-person examinations; however, a recent study shows that telehealth visits can be a part of treatment plans.
Read MoreOct 17, 2023
Patients with tardive dyskinesia being treated with vesicular monoamine transporter 2 inhibitors may see improvement in well-being along with TD symptoms.
Read MoreOct 13, 2023
A curated ebook on lung cancer biomarkers featuring recent studies, findings, and opinions from thought leaders.
Read MoreOct 9, 2023
Between 20% and 30% of patients with schizophrenia (SCZ)—and up to 50% patients with SCZ older than 50—develop tardive dyskinesia (TD), according to a study published in Genes & Genomics.
Read MoreSep 14, 2023
An uptick in biomarker testing for non-small cell lung cancer (NSCLC) over the past decade indicates an ongoing trend toward personalization of treatment choices.
Read MoreSep 13, 2023
A quiz based on the latest tardive dyskinesia news and studies.
Read MoreSep 12, 2023
First-line treatment that aligns with the results of biomarker testing and treatment guidelines is linked with better survival outcomes in patients with advanced or metastatic NSCLC.
Read MoreSep 5, 2023
A curated ebook on tardive dyskinesia (TD) featuring recent studies, findings, and opinions from thought leaders.
Read MoreAug 21, 2023
Biomarker testing in non-small cell lung cancer informs therapeutic decisions at all stages of...
Read More